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malaria infection triggers pro-inflammatory responses in humans that are detrimental 
to host health. Parasite-induced enhancement in cytokine levels correlate with malaria-
associated pathologies. Here we show that parasite tyrosyl-tRnA synthetase (PfTyrRs), 
a housekeeping protein translation enzyme, induces pro-inflammatory responses from host 
immune cells. PfTyrRs exits from the parasite cytoplasm into the infected red blood cell (iRBC) 
cytoplasm, from where it is released into the extracellular medium on iRBC lysis. using its ELR 
peptide motif, PfTyrRs specifically binds to and internalizes into host macrophages, leading to 
enhanced secretion of the pro-inflammatory cytokines TnF-α and IL-6. PfTyrRs-macrophage 
interaction also augments expression of adherence-linked host endothelial receptors ICAm-1 
and VCAm-1. our description of PfTyrRs as a parasite-secreted protein that triggers pro-
inflammatory host responses, along with its atomic resolution crystal structure in complex with 
tyrosyl-adenylate, provides a novel platform for targeting PfTyrRs in anti-parasitic strategies. 
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Aminoacyl-tRNA synthetases are ancient enzymes responsible for genetic code translation1. These ubiquitous enzymes attach amino acids onto cognate transfer RNAs during pro-
tein translation, and are divided into two classes based on their 
structural topology1,2. Class I synthetases, like tyrosyl-tRNA syn-
thetase (TyrRS), are characterized by a Rossmann fold, and this 
class contains two conserved ATP-binding motifs (HIGH and 
KMSKS)3,4. Apart from their parent aminoacylation activity, several 
aminoacyl-tRNA synthetases perform non-canonical functions in 
transcriptional regulation, apoptosis, ribosomal RNA biogenesis, 
angiogenesis and cell signalling5–8. Human TyrRS is processed by 
an elastase enzyme yielding an amino-terminal TyrRS (also known 
as mini-TyrRS) and carboxy-terminal EMAPII-like domain9–13. The 
latter contains cell signalling activity whereas human mini-TyrRS 
mimics interleukin-8 (IL-8) to chemo-attract polymorphonuclear 
cells9–13. Human mini-TyrRS interacts with CXCR1/2 receptors and 
acts as an angiogenic cytokine using a motif called ELR (Glu-Leu-
Arg) that it shares with IL-8 (Fig. 1a). For the human mini-TyrRS 
ELR motif to be functional, the intact human enzyme is required to 
undergo proteolytic cleavage, which results in the release of EMA-
PII domain and subsequent exposure of the ELR motif 9–13.
Plasmodium parasites are the causative agents of malaria. It is 
estimated that  > 300 million clinical malaria cases occur annually, 
resulting in  > 1 million deaths14. Malaria-related deaths occur owing 
to a range of syndromes including acute anemia and/or cerebral/
placental malaria14,15. Most malaria pathology results from an acute 
inflammatory spurt, followed by activation of the host immune 
system and dysregulated cytokine release14–18. Human patient studies 
and mouse malaria models have consistently suggested that infec-
tion by the malaria parasite triggers an increase in the levels of 
numerous pro-inflammatory agents including tumour necrosis 
factor (TNF-α), interferon gamma (IFN-γ) and interleukin 6 (IL-6) 
in blood plasma19–21. Although pro-inflammatory cytokines have a 
major role in patho-physiology of malaria disease16–21, the molecular 
mechanisms of cytokine release from immune cells remains largely 
unclear. Until now, several parasite-derived molecular agents have 
been implicated in triggering cytokine release22–25, but parasite-
secreted protein(s) that potentially trigger specific cytokine secre-
tion from host immune cells are less well understood. It is critical 
to understand the pathways and mechanisms that lead to cytokine 
release in malaria as disease pathology, directly or indirectly, gen-
erally results from dysregulation of circulating TNF-α and IL-6 
amounts22–25.
Plasmodium falciparum genome contains two copies of tyrosyl-
tRNA synthetase-tyrosyl-tRNA synthetase 1 (hereafter PfTyrRS, 
Plasmodb ID = MAL8p1.125) and tyrosyl-tRNA synthetase 2 (here-
after PfTyrRSapi, Plasmodb ID = PF11_0181). PfTyrRS was predicted 
to be cytoplasmic whereas PfTyrRSapi is probably targeted to the 
parasite apicoplast6. Here we have investigated the structural, immu-
nological and spatial localization attributes of PfTyrRS. Our com-
prehensive analyses provide a platform for focusing on PfTyrRS as a 
new target for development of novel malaria intervention strategies.
Results
PfTyrRS characterization and structure. Bacterially overexpressed 
PfTyrRS was purified to homogeneity using affinity and gel-filtration 
chromatography, and the protein migrates as a dimer (Fig. 1b). 
PfTyrRS enzyme activity was confirmed using tRNAs obtained by 
in vitro transcription using T7 RNA polymerase (Fig. 1c)26–28. We 
determined the three-dimensional structure of PfTyrRS in complex 
with YAP (tyrosyl-adenylate) to a resolution of 2.2 Å (Fig. 2a,b; 
Table 1). The crystallographic asymmetric unit contains a canonical 
tyrosyl-tRNA synthetase dimer. Eighteen N-terminal and three 
C-terminal residues were not clearly defined in the electron density 
for each monomer. The overall fold of PfTyrRS is typical of class I 
synthetases3,4 and comprises a catalytic domain (residues 18–260, 
Rossmann fold) and an anti-codon-binding domain (residues 
261–370). Human mitochondrial and malaria parasite apicoplastic 
TyrRS belong to bacterial lineage, whereas human cytoplasmic 
TyrRS and PfTyrRS belong to a separate eukaryotic group6,29  
(Fig. 2c). Structural superposition of 292 Cα atoms between PfTyrRS 
and human mini-TyrRS (Protein Data Bank, accession code 
1N3 L) gives an RMSD of ~1.9 Å (sequence identity ~30%), whereas 
the RMSD between 144 Cα atoms of PfTyrRS and mitochondrial 
HsTyrRS (PDB: 2PID) is ~2.5 Å (sequence identity  < 10%). In 
PfTyrRS, the solvent accessible buried surface area at dimer 
interface is ~1,337 Å2, and its value is comparable with l-Tyr 
bound mini-HsTyrRS (1,380 Å2) but not with the unliganded mini-
HsTyrRS (buried area of 1,531 Å2). In mini-HsTyrRS structure13, 
the adenosine binding pocket is empty and seems enlarged by 
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Figure 1 | Tyrosyl tRNA synthetase domain organization and enzyme 
characterization. (a) Domain organization of TyrRs from P. falciparum, 
human and yeast. The 21 residue n-terminal extension in PfTyrRs is shown 
in orange. The ELR motif is shown in red and in yeast TyrRs it is replaced by 
nYR. (b) Gel filtration curves show both wild-type PfTyrRs (solid blue line) 
and ELR/AAA mutant (dotted red line) proteins as dimers in solution.  
(c) Aminoacylation curves with (blue line) and without (red line) added 
native PfTyrRs and using Pf-tRnATyr. 
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~3 Å on either side of the binding pocket whereas, in YSA (5′-O- 
[N-(l-Tyrosyl) sulfamoyl] adenosine)-bound mitochondrial 
HsTyrRS29 and in YAP-bound PfTyrRS, the adenosine-binding 
pocket is tighter (Fig. 2d). In PfTyrRS, the key synthetase 
motif of KMSKS loop is highly ordered and close to the bound 
substrate at the active site, whereas, in both cytoplasmic and 
mitochondrial HsTyrRS, this is found to be disordered (Fig. 2d). 
We find several other key structural differences between mini-
HsTyrRS and PfTyrRS (Fig. 2c,d). First, at the primary sequence 
level, PfTyrRS has an N-terminal 21 residue extension whose role 
is unclear (Fig. 1a). On the other hand, human cytoplasmic TyrRS 
has a C-terminal extension in the form of an EMAPII domain that 
undergoes proteolytic processing to reveal a host module more 
similar in size to PfTyrRS9–13 (Fig. 1a). The most notable and intriguing 
feature of both the mini-HsTyrRS and PfTyrRS is presence of an 
ELR motif (Figs. 1a and 2e). This tri-peptide signature is present in, 
among others, cytokines like IL-8 (refs 9–13,30). As shown in Figure 
2e, ELR motifs decorate the surfaces of IL-8, mini-HsTyrRS and 
PfTyrRS. Structural alignment of ELR motifs from these three reveals 
striking conformational conservation (RMSD  < 1 Å). In PfTyrRS, 
the ELR motif resides on α-helix 2 whereas, in mini-HsTyrRS, it is 
located at α-helix 5 (Fig. 2e). In both PfTyrRS and mini-HsTyrRS, 
the ELR motif is significantly distal from aminoacylation sites (Fig. 
2e). In full-length cytoplasmic HsTyrRS, the ELR motif is buried 
under the C-terminal EMAPII domain, and this motif is exposed 
after proteolytic cleavage9–13. In contrast, the PfTyrRS ELR motif is 
exposed in three-dimensional space and does not require processing 
for its surface display. Therefore, in the parasite enzyme the ELR 
tri-peptide is continually solvent accessible owing to its presence 
in a different part of the overall three-dimensional structure 
relative to human TyrRS (Fig. 2a,e). Subtle structural perturbations 
caused by single residue mutations near the ELR motif can activate 
procytokine activity of human TyrRS11. These data on human 
TyrRS11 suggested that the twin attributes of cytokine trigger and 
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Figure 2 | Crystal structure of PfTyrRS. (a) PfTyrRs:Tyr-AmP (YAP) complex structure where the ELR, KmsKs and HIGH motifs are shown in red, yellow 
and orange, respectively. Bound YAP is shown in stick model (green). (b) stereoview of the experimental electron density map (2|Fo|-|Fc|) for a portion of 
the final atomic model. The map is contoured at 1.2 σ level. (c) sequence alignment between mini-HsTyrRs and PfTyrRs. Important motifs are highlighted 
in red boxes and the ELR motifs are marked. (d) A close-up view of KmsKs loop and active site region of PfTyrRs along with corresponding regions from 
cytoplasmic mini-HsTyrRs and mitochondrial HsTyrRs (with 5′-o-[n-(l-Tyrosyl) sulfamoyl] adenosine also known as YsA). The disordered KmsKs loop 
is shown as dotted lines in human structures and the bound substrate/analog is shown as sticks. (e) structural alignment and ELR motifs in mini-HsTyrRs 
(purple), PfTyrRs (green) and HsIL-8 (orange). 
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aminoacylation can coexist in a tyrosyl-tRNA synthetase11. Indeed, 
our description of the parasite PfTyrRS provides an excellent natural 
example of a synthetase enzyme with constitutively active ELR 
motif (Fig. 2). Interestingly, the ELR motif is absent in TyrRSs from 
lower eukaryotes and prokaryotes (Fig. 1a), again suggesting that 
ELR motif is independent of the parent aminoacylation activity of 
these enzymes.
Structural comparisons suggest sequence differences in 11 key 
residues that contribute to l-Tyr binding (5 residues) and adeno-
sine binding (6 residues) between human and parasite enzymes 
(Fig. 2c,d). Residues in the conserved HIGH and KMSKS motifs 
are different between PfTyrRS (HIAQ and KMSKS) and mini-
HsTyrRS (HAVY and KMSSS). In the l-Tyr bound mini-HsTyrRS, 
a K +  ion is bound near adenine binding pocket whereas this space is 
empty in unliganded state of mini-HsTyrRS. In PfTyrRS, there is no 
density for an ion like K + , and further the residues involved in K +  
ion coordination in mini-HsTyrRS are not conserved in PfTyrRS. 
Therefore, several subtle yet crucial differences between host and 
pathogen tyrosyl-tRNA synthetase active sites (Fig. 2b–d) present 
a window for exploiting the malaria parasite enzyme for structure-
based inhibitor discovery—consistent with recent high-throughput 
chemical library screening data31.
Parasite and erythrocyte localization of PfTyrRS. Confocal 
microscopy was performed using protein-A purified IgG fraction 
of rabbit antibodies that were raised against recombinant PfTyrRS. 
Our localization data show that PfTyrRS is present in all three 
stages of asexual parasite life cycle: rings, trophozoites and schi-
zonts (Fig. 3a; Supplementary Movies 1, 2 and 3 based on z-stacked 
confocal analyses of rings, trophozoites and schizonts, respec-
tively—DAPI is in blue and PfTyrRS in green). Closer examination 
of PfTyrRS localization in infected erythrocytes during tropho-
zoite and schizont stages revealed possible secretion of PfTyrRS 
into infected red blood cell (iRBC), despite absence of an export 
signal in PfTyrRS sequence (Fig. 3a). Similar results were obtained 
using PfTyrRS-GFP fusion parasite transgenic cell lines (Fig. 3b). 
We therefore tested whether secretion of PfTyrRS occurred from 
schizonts at time of iRBC rupture. To address this, culture super-
natants of infected RBCs were separated on SDS–PAGE, and west-
ern blotting was performed using anti-PfTyrRS antisera (Fig. 3c). 
This experiment indicated a band of ~42 kDa in iRBC medium that 
corresponds to the molecular size of PfTyrRS. As controls, the para-
site-secreted MSP1 and non-secreted proteins like DTD32,33 and fal-
cipain 2 were also used (Fig. 3c). We also performed western blot 
analysis using anti-GFP antibody on PfTyrRS-GFP parasite cell line 
supernatants. PfTyrRS-GFP fusion protein band of expected molec-
ular weight (70 kDa) was clearly seen in iRBCs supernatants but 
not in supernatants from uninfected RBCs controls (Fig. 3d). These 
experiments suggest that PfTyrRS is expressed in all asexual para-
site stages, and that it is exported to the host erythrocyte cytosol, 
from where it is released into blood plasma on iRBC rupture.
PfTyrRS interaction with host immune cells. Release of PfTyrRS 
from iRBCs and the presence of an exposed and conformationally 
competent ELR motif persuaded us to address directly the binding 
of TyrRS to host immune cells. We performed an in vivo experi-
ment where mice were infected with Plasmodium yoelii (XNL). 
Subsequently, spleen cells containing peripheral blood mono-
nuclear cells (PBMCs) were isolated from these infected mice and 
then presence of native TyrRS was tested using anti-TyrRS-specific 
antibodies by flow cytometry (Fig. 4a). We observed specific TyrRS 
binding to mouse macrophages and dendritic cells, among others 
(Fig. 4a). A corresponding in vitro experiment using human 
PBMCs also showed specific interaction of PfTyrRS with human 
macrophages and, to a lesser degree, with dendritic cells (Fig. 4b). 
To validate these observations further, we assessed binding of 
PfTyrRS to mouse and human immune cells using confocal 
microscopy (Fig. 4c,d). We detected both binding and internali-
Table 1 | Data collection and refinement statistics.
Parameters PfTyrRS-YAP
Data collection
 space group C2
 unit cell dimensions
  a, b, c (Å) 137.5, 46.5, 141.3
  α, β, γ (°) 90, 93.8, 90
 Resolution (Å) 50.0–2.2
 Rmerge 0.056 (0.405)
 I/σ(I) 51.0 (4.8)
 Completeness (%) 94.7 (82.2)
 Redundancy 14.1 (9.8)
Refinement
 Resolution (Å) 50.0–2.2
 no. of reflections 42,842
 Rwork/Rfree 0.172/0.214
No. of atoms
 Protein (two molecules) 5,726
 Ligand/waters 70/371
B-factors (Å2)
 Protein 57
 Ligand/waters 39/61
R.m.s. deviations
 Bond lengths (Å) 0.007
 Bond angles (°) 1.09
Values in parentheses are for highest-resolution shell.
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Figure 3 | Cellular localization of PfTyrRS. (a) Confocal microscopy of  
P. falciparum asexual stages—rings, trophozoites and schizonts using anti-sera 
raised in rabbits against PfTyrRs. scale bar in red corresponds to a size of 5 µm 
(b) Confocal microscopy using anti-GFP antibody (green) in PfTyrRs-GFP 
transgenic parasite cell lines. Parasite nucleus was stained with DAPI (blue) 
in each case. scale bar in red corresponds to a size of 5 µm. (c) Enhanced 
chemi-luminiscence of parasite culture supernatants using antibodies 
against PfTyrRs, PfDTD, PfmsP1 and Pf falcipain 2 and (d) Enhanced chemi-
luminiscence of parasite culture supernatants using anti-GFP antibody. 
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zation of PfTyrRS by host macrophages. Supplementary Movie 4  
is based on Z-stacking of these confocal images where macro-
phages are stained for nucleus (DAPI, blue) and for PfTyrRS (in 
green). These data led us to hypothesize an ELR-motif-mediated 
interaction of P. falciparum tyrosyl-tRNA synthetase with human 
macrophages (Fig. 4c,d).
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Figure 4 | TyrRS interaction with PBMCs in vivo and in vitro. (a) FACs-based binding of mouse PBmCs with anti-PfTyrRs antibodies in an ex vivo 
experiment. Left panel shows gating; middle panel shows TyrRs binding in immune cells tested in both uninfected and infected mice. overlay histograms 
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and dendritic cells. Left panel shows gating; middle panel shows PfTyrRs binding to various immune cells. The overlay histogram is derived from PfTyrRs-
binding dot plots wherein solid grey histogram is without PfTyrRs and black solid line is with PfTyrRs. Confocal images of binding and internalization of 
PfTyrRs into (c) mouse dendritic cells (top panel), mouse macrophages (bottom panel) and (d) human macrophages. In (d) along with wild-type PfTyrRs 
(green), the controls of pre-immune sera, ELR/AAA mutant PfTyrRs, and primary/secondary antibodies alone (that is, no added PfTyrRs) are shown. For 
nucleus visualization, DAPI (blue) localization is also shown. The red scale bar in confocal images corresponds to a size of 15 µm. 
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Triggering of cytokine secretion by PfTyrRS. Our observations on 
interaction of PfTyrRS with host immune cells prompted us to test 
whether the ELR motif present in PfTyrRS could enable it to trigger 
release of cytokines from macrophages. We tested this hypothesis 
by incubating mouse and human macrophage cell lines with recom-
binant wild-type PfTyrRS, with a mutant ELR/AAA-PfTyrRS, with 
lipopolysaccharide (LPS) (as positive control), with media alone and 
PfDTD (last two as negative controls). In these studies, the amounts 
of PfTyrRS used were in nanomolar (nM) concentration ranges, 
similar to amounts used in studies with human mini-TyrRS9–13. 
Time kinetic analysis using ELISA revealed maximal production of 
the inflammatory cytokines TNF-α, IL-6 and IL-1(α and β) within 
6 hours of culture (Tukey’s test—P < 0.001) (Fig. 5a,b), but not of 
IL-10 or IL-12 (Fig. 5c). The cytokine release mediated by PfTyrRS 
was dose-dependent, and occurred as early as 4 hours post-incu-
bation of macrophages with PfTyrRS (Fig. 5d). Interestingly, the 
mutant PfTyrRS (where ELR was replaced with AAA sequence) 
did not trigger cytokine release from macrophages and behaved 
similar to the control proteins PfDTD32,33 or PfSerRS. In all experi-
ments, LPS was used as a positive control, and all proteins used in 
these experiments were confirmed to be endotoxin free (Methods). 
We also observed that PfTyrRS that had been immunoprecipitated 
from parasite culture supernatants was equally capable of trigger-
ing release of TNF-α and IL-6 from human macrophage ThP1 cell 
lines (Fig. 5e). Finally, pre-incubation of PfTyrRS with anti-PfTyrRS 
antibodies substantially blocked TNF-α (Tukey’s test—P < 0.05) and 
IL-6 production (Tukey’s test—P < 0.01) from human macrophages 
(Fig. 5e), suggesting specific, motif-based PfTyrRS interaction with 
human macrophages.
Potential receptor(s) for PfTyrRS on human macrophages. To 
identify a receptor for PfTyrRS on macrophages, we pre-incubated 
human macrophages with anti-CXCR1/2 and anti-PfTyrRS anti-
bodies, and tested whether antibody-mediated receptor or protein 
blockades inhibited PfTyrRS-macrophage interaction (Fig. 6a). 
Specific antibody-mediated blocking of CXCR2 receptor (Tukey’s 
test—P < 0.05), but not the CXCR1 receptor, on human macro-
phages reduced PfTyrRS binding by ~twofold (Fig. 6a). Blocking of 
PfTyrRS with anti-PfTyrRS antibodies also reduced binding of the 
protein to macrophages (Tukey’s test—P < 0.05) (Fig. 6a). Further-
more, blockage of PfTyrRS-macrophage interactions using either 
anti-CXCR2 or anti-PfTyrRS antibodies also significantly reduced 
the release of TNF-α (Tukey’s test—P < 0.05) and IL-6 (Tukey’s test—
P < 0.001) from human macrophages (Fig. 6b). To further probe the 
significance of ELR motif in binding of PfTyrRS to macrophages, we 
tested inhibition of PfTyrRS-macrophage interaction using peptides 
in which the wild-type PfTyrRS ELR peptide sequence (DELRV) 
was mutated residue-wise to DELAV, DAAAV and DELKL. Fluo-
rescence-activated cell sorting (FACS)-based binding studies of 
PfTyrRS in presence of 100 nM of these peptides showed a signifi-
cant reduction in binding with only the DELRV peptide sequence 
(Fig. 6c). The DELKL peptide was less competent in competing 
whereas the other two peptides did not compete at all (Fig. 6c). 
Additionally, the PfTyrRS-triggered release of TNF-α and IL-6 
from human macrophages was significantly reduced in presence of 
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Figure 5 | Effect of PfTyrRS on mouse macrophages. (a) Cytokines levels 
were measured using BioPlex kit (Bio-Rad) and the secretion profiles of 
TnF-α and IL-6 using mouse macrophages were measured at different 
time points. media alone, PfDTD/PfserRs enzymes and ELR-AAA mutant 
of PfTyrRs were used as negative controls. LPs was used as positive 
control in all experiments. (b) Identical experiment as in (a) except that 
the human macrophage cell line ThP1 was used. This experiment has the 
extra negative control of PfserRs. (c) secretion profiles of extra cytokines 
(IL-1, IL-10 and IL-12) that are secreted from human macrophages on 
exposure to PfTyrRs. (d) Dose-dependent increase in secretion of TnF-α 
and IL-6 when increasing concentrations of PfTyrRs were used with human 
macrophages. (e) Cytokine secretion profiles using P. falciparum culture 
supernatants alone (sup), supernatants incubated with anti-TyrRs antibody 
(sup + αTyrRs), parasite culture supernantant-immunoprecipitated PfTyrRs 
(PD-TyrRs) and finally parasite culture supernantant -immunoprecipitated 
PfTyrRs with its antibody (PD-TyrRs  +  αTyrRs). TnF-α and IL-6 secretion 
is clearly enhanced significantly when immunoprecipitated PfTyrRs (PD-
TyrRs) is used. Triggering activity of PfTyrRs (PD-TyrRs) is blocked when 
pre-incubated with anti-PfTyrRs antibodies, indicating specific activation of 
macrophages with native PfTyrRs (PD-TyrRs). Experiments were repeated 
three times and error bars indicate standard deviation. Tukey’s test was 
performed and P-values are shown such that the end points of the lines 
below P-value represent the datasets that were compared.
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DELRV peptide (Tukey’s test—P < 0.05) (Fig. 6d). These data, along 
with our observation that the ‘ELR/AAA’ PfTyrRS mutant does not 
bind to human macrophage cells (Fig. 4c,d), strongly highlight a role 
for ELR motif in PfTyrRS interactions with human macrophages. 
We therefore conclude that ELR-motif-based PfTyrRS binding likely 
occurs using specific receptors on human macrophages, and that 
this binding leads to very specific host immune system activation.
PfTyrRS-stimulated macrophage upregulate ICAM-1 and 
VCAM-1. P. falciparum cytoadherence enables parasite seques-
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Figure 6 | Potential PfTyrRS receptor on human macrophages. (a) FACs analysis of PfTyrRs binding to human macrophages. PfTyrRs binding to 
macrophages is reduced when macrophages had been pre-incubated anti-CXCR2 or with anti-PfTyrRs antibodies. Binding was not reduced significantly 
with anti-CXCR1 antibodies. overlay histograms show binding of PfTyrRs to the surface of human macrophages (black line) with unstained controls 
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tration in host tissues, allowing these parasites to avoid splenic 
clearance which involves degradation and clearing of infected RBCs 
by the spleen34–40. In severe malaria episodes, an increase in the 
levels of TNF-α is coupled with enhanced expression of endothelial 
cell receptors such as ICAM-1 (intercellular adhesion molecule-1), 
VCAM-1 (vascular cell adhesion molecule-1) and E-selectin34–40. 
We therefore tested whether recombinant PfTyrRS could modulate 
expression of endothelial receptors in a static cytoadhesion model 
assay system. For this ‘triggering’ to work, PfTyrRS had to first initiate 
enhanced secretion of cytokines like TNF-α from macrophages, and 
then the increased levels of secreted cytokines would have to induce 
overexpression of endothelial receptors like ICAM-1 and VCAM-1. 
As our experimental data show, this is indeed what PfTyrRS was 
able to achieve (Fig. 7). When HUVECs (primary human umbilical 
vein endothelial cells) were co-cultured with culture supernatants 
of PfTyrRS-activated macrophages, we found strong upregulation of 
both ICAM-1 and VCAM-1 receptors (Tukey’s test—P < 0.05) (Fig. 
7a). A PfTyrRS-induced dose-dependent increase in expression of 
ICAM-1 was also evident (Fig. 7b). These effects were not due to 
cell toxicity of PfTyrRS on HUVECs (Fig. 7c). These experiments 
therefore provide fundamental molecular insights and also a tool 
to dissect the molecular basis of cytoadherence using PfTyrRS as a 
‘trigger’. Increased levels of circulating cytokines in malaria infected 
individuals may activate the host immune system to check or con-
trol very high parasitemia levels, which may prove lethal both to 
pathogen and host.
Discussion
One of the key pathogenic mechanisms in the virulence of 
P. falciparum is the phenomenon of cytoadherence, attributed to 
increased adhesion of infected erythrocytes to blood capillaries34–42. 
In particular, cerebral and placental malaria seem to be dependent 
on crucial protein–protein interactions that occur between a para-
site virulence factors and the endothelial/placental receptors34–42. 
The host immune system is hijacked by parasite-derived factors to 
assist in cytoadherence, for example, by cytokine-induced increased 
expression of a range of adhesion molecules16,18–25. Numerous field 
reports on human malaria and mouse model studies have shown 
that malaria infection alters host cytokine profiles by modulating 
dendritic cells and macrophages16,18–25. This is presumably done to 
aid in parasite survival and transmission. Elevated cytokine levels 
have a variety of physiological effects, generally to the detriment of 
the hosts16,34–42. In fact, malaria as a disease has been looked up on 
as a manifestation of enhanced pro-inflammatory cytokine produc-
tion in host16,34–42. For example, the clinical manifestations of severe 
malaria can be correlated with induction of strong pro-inflammatory 
responses in which plasma levels of circulating TNF-α, IFN-γ and 
IL-6 increase significantly19–21. Pathways that propel host immune 
cell activation in malaria remain mysterious in context of parasite-
derived protein antigens. The interaction of latter with macrophages 
and dendritic cells must occur before cytokine induction. So far, 
studies have identified several such molecular agents2–22, but, to our 
knowledge, no parasite-secreted housekeeping enzyme has been attri-
buted with the ability to trigger enhanced secretion of cytokines like 
TNF-α and IL-6. In this context, we find it very interesting that the 
levels of TNF-α secreted from immune cells reported in previous 
studies22–25 are similar to or lower than those we report with PfTyrRS. 
A comparison of secreted TNF-α levels (pg ml − 1) is illuminating—
using 100 nM PfTyrRS: 1,000–1,300 pg ml − 1, 50–400 nM GPIs; 800–
1,300 pg ml − 1, ~µg ml − 1 DNA-protein complexes; 500–600 pg ml − 1 
and 30–100 µM hemozoin; 400–600 pg ml − 1, ~500,000 micropar-
ticles; 150–200 pg ml − 1. This comparison indicates importance of 
PfTyrRS as a trigger for excitation of pro-inflammatory cytokine 
release from host immune cells.
Our corroborative confocal microscopy data not only reveals 
decoration of host macrophage surfaces with PfTyrRS but also its 
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Figure 7 | PfTyrRS stimulation of macrophages and subsequent 
upregulation of endothelial receptors ICAM-1 and VCAM-1. (a) HuVEC 
cells (Hu) were incubated with PfTyrRs alone, PfDTD (negative control 
protein (CoRL), macrophage cells (φ) and TnF-α. Culture supernatants 
of PfTyrRs-induced macrophages and PfDTD-induced macrophages 
were added to HuVEC cell lines. Expression of ICAm-1 and VCAm-1 
was measured by FACs using specific conjugated antibodies. Grey bars 
(left) represent VCAm-1 expression and black bars (right) represent 
ICAm-1 expression. (b) PfTyrRs-induced dose-dependent increase in 
the expression of ICAm-1. no upregulation of ICAm-1 was observed on 
addition of ELR/AAA PfTyrRs mutant to endothelial cell lines. Bars in 
black represent PfTyrRs treated samples, whereas bars in grey were the 
samples treated with ELR/AAA mutant protein (c) mTT cytotoxicity 
assay with dose-dependent response using PfTyrRs (red line), ELR/AAA 
mutant (green line), and control (only cells in blue line) on HuVEC cells. 
no decrease in cell viability was observed (Tukey’s test—P > 0.05). The 
optical density on y axis in (c) represents cell survival in an mTT assay. 
Experiments were repeated three times and the error bars represent 
standard deviation. Tukey’s test was performed and P-values are shown 
such that the end points of the lines below P-value represent the datasets 
that were compared. ns, not significant.
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internalization. We propose that, as a result of PfTyrRS-macrophage 
interactions, significantly higher amounts of pro-inflammatory 
cytokines like TNF-α, IL-1 and IL-6 are released. Elevated cytokine 
levels can have severe effects in hosts and severe malarial anemia 
(SMA) provides an excellent example of this45. Increased circulating 
TNF-α inhibits erythroblast differentiation and dampens erythro-
poiesis resulting in worsening SMA symptoms16–21,45. Another 
outcome of higher levels of circulating TNF-α in infected malaria 
patients is the increase in expression levels of certain endothelial 
receptors like ICAM-1, VCAM-1 and E-selectin that contri-
bute to cytoadherence in severe malaria39–42. Our data based on 
co-incubation of three components—purified PfTyrRS macro-
phages and endothelial cells, now provides a system that can be 
further dissected to investigate molecular and cellular interactions 
that occur during SMA and cytoadherence. This work therefore 
provides clues to the possibility of PfTyrRS acting as a malarial toxin 
that can induce cytokine-mediated disease.
Aminoacyl-tRNA synthetases have a vital role in translating the 
genetic code. Numerous studies have shown that members of this 
enzyme family are quite adept at ‘moonlighting’ in terms of possess-
ing extra capabilities that widen their biological attributes5–8. Studies 
have indicated that human tyrosyl-, tryptophanyl- and lysyl-tRNA 
synthetases can be secreted extracellularly and can mimic cytokines5–8. 
For these extra roles, the human TyrRS and TrpRS require either prote-
olytic cleavage or alternate splicing to become active5–9, whereas LysRS 
can act like a cytokine without processing44. In this light, this is the first 
report of a human pathogen tRNA synthetase that can also perform 
moonlighting activity of inducing host immune system to release pro-
inflammatory cytokines. In summary, this study suggests that PfTyrRS 
is secreted from the parasite and deposited proximal to iRBC membrane 
(despite lack of a ‘PEXEL’ export element43). PfTyrRS egress occurs 
during trophozoite and schizont stages, before iRBC rupture. On iRBC 
lysis, PfTyrRS is released into blood plasma, where it is potentially free 
to interact with host cells. We show that PfTyrRS interacts with specific 
receptor(s) on host macrophages, and that this event is largely medi-
ated by the ELR motif present in PfTyrRS. Finally, we have determined 
the three-dimensional structure of PfTyrRS in complex with Tyr-AMP, 
and provide detailed structural comparisons with host counterpart of 
PfTyrRS. This work therefore not only provides a structural frame-
work for using PfTyrRS-YAP complex structure as a starting point for 
structure-based drug discovery, but also lays foundation for probing 
key immunological questions in malaria. The twin abilities of malaria 
parasite tyrosyl-tRNA synthetase—as a housekeeping protein transla-
tion enzyme and as a trigger for pro-inflammatory cytokine release 
in hosts—highlight this protein as a target for discovery of novel anti-
parasitic strategies.
Methods
Animal experiments. Animal experiments were performed in accordance with 
Institutional Animal Ethics Committee guidelines approved by Department of 
Biotechnology, Govt of India. This project was approved in a meeting held on 28 
October 2009 at ICGEB (approval ID: ICGEB/IAEC/MAL-50). All mice used were 
killed ethically by asphyxiation in carbon dioxide according to regulatory body 
instructions.
Synthetic tRNA preparation and aminoacylation assay. Synthetic Plasmodium 
falciparum tRNA clones were obtained according to Sampson and Uhlenbeck46  
by assembling up to 6 oligonucleotides and ligation between HindIII and BamHI 
sites into pUC19 vector. The tRNAs were obtained by in vitro transcription using 
T7 RNA polymerase according to standard protocols. In vitro tRNA aminoacyla-
tion assays were performed at 37 °C in 50 mM Tris–HCl pH 7.6, 50 mM KCl, 
25 mM MgCl2, 5 mM ATP, 0.1 mg ml − 1 BSA, 1 mM DTT, 20 µM tyrosine, 0.5 
mCi ml − 1 l–[3,5-3H]tyrosine and 0.5 µM PfTyrRS as reported47. Reaction was initi-
ated by addition of pure enzyme and samples of 20 µl were spotted onto Whatman 
3 mM discs at varying time intervals (usually 2 min). Radioactivity (corresponding 
to amino acid ligated to tRNA substrate) was measured by liquid scintillation.
Protein expression, purification and crystallization. TyrRS gene (MAL8P1.125). 
from P. falciparum was PCR amplified from complementary DNA and cloned  
into pQE30 vector (Qiagen). Four hours post -IPTG (isopropyl 1-thio-d- 
galactopyranoside, 0.5 mM) induction, the bacterial cell pellet was suspended in 
buffer containing 50 mM Tris–HCl, 500 mM NaCl, 50 mM imidazole, pH 8.0 and 
protease inhibitor cocktail. Protein was purified using Ni-NTA beads (Qiagen) and 
gel filtration chromatography. Pure, dimeric PfTyrRS was concentrated and buffer 
exchanged into 25 mM Tris–HCl pH 8.0, 150 mM NaCl and 10 mM BME. Dif-
fraction quality crystals using His-tag-free PfTyrRS were grown by hanging drop 
vapour diffusion method at 20 °C. The droplet size was 1 µl of protein (30 mg ml − 1 
in 25 mM Tris pH 8.0, 100 mM NaCl, 10 mM BME, 10 mM MgCl2, 10 mM ATP  
and 2 mM l–tyrosine) with 1 µl of reservoir solution equilibrated over 200 µl of 
2.4 M sodium malonate at pH 6.0.
Data collection and structure determination. A single crystal was transferred to 
cryoprotectant reagent (paratone oil) for a short period (5–10 s) before freezing in a 
stream of cooled nitrogen gas. Data were collected at 100 K using Cu Kα radiation 
(λ = 1.54 Å) on a MAR345 image-plate detector mounted on a Rigaku MicroMax-
007 rotating-anode X-ray generator. A total of 700 frames were collected in 1° 
oscillation steps with 5 min exposure per frame, and data were processed with 
HKL2000 (ref. 48). The structure was solved by molecular replacement in MOL-
REP49 using cytoplasmic mini-HsTyrRS (PDB: 1N3L) as a starting model. Iterated 
manual model building and refinement was done using COOT50 and phenix.
refine51. The structural representations in this paper were prepared with Chimera52 
and PyMOL (http://www.pymol.org).
Cell-binding assays. For in vitro localization experiments, synchronous parasite 
cultures of P. falciparum 3D7 were washed with PBS, fixed in solution using 4% 
paraformaldehyde and 0.0075% glutraldehyde for 20 min, permeablized with 0.1% 
Triton X-100 for 10 min and then treated for 10 min with 0.1 mg ml − 1 sodium  
borohydride in PBS. Each step was followed by a brief PBS wash53. Cells were 
blocked in 3% BSA, PBS for 1 h, washed in PBS and incubated overnight with 
protein-A column purified rabbit anti-PfTyrRS antibodies (1:150 dilution in PBS 
containing 3% BSA) at 4 °C. After three washes (10 min each) with PBS, the cells 
were incubated with Alexa Fluor488-conjugated anti-rabbit secondary antibody 
(1:250 dilution in PBS containing 3% BSA) for 2 h at room temperature and  
allowed to settle onto poly-d-lysine (100 mg ml − 1)-coated coverslips. These were 
then washed three times in PBS and mounted in antifade with DAPI (Molecular 
Probes). Spleen cells were purified from P. yoelii-infected mice and PBMCs were 
isolated from both mouse and human blood as described earlier54. For the in vivo 
experiment, C57BL/6 mice were infected with ~1 million P. yoelii (17XNL strain) 
in the form of parasitized RBC’s intraperitoneally. Fifteen days after infection, the 
spleens were collected from infected and age-and-sex matched uninfected control 
mice. Spleens were crushed and lymphocytes were isolated and stained for  
flow cytometry by standard procedures. The cells were fixed with Cytofix  
(BD Biosciences) and permeabilized with 1X Cytoperm (BD Biosciences) for  
intracellular TyrRS staining. The data was acquired on BD FACS Canto II  
(BD Biosciences) and analysed on by FlowJo software (Treestar). Human PBMCs 
were isolated using BD Vacutainer CPT tubes (BD Biosciences) by centrifugation  
at 1,600 g per 25 min/RT/no brake. The cells were thoroughly washed and  
resuspended in complete RPMI containing 10% FCS in a 24-well plate, and 100 nM 
purified PfTyrRS protein was added for 3 h at 37 °C (95% humidity, 5% CO2).  
Analytical flow cytometry was performed by direct staining for specific popula-
tions of immune cells with fluorescently conjugated antibodies and biotin- 
conjugated anti-PfTyrRS antibody (1:150 dilution in PBS). The data obtained on 
BD FACS Canto II (BD Biosciences) was analysed using FlowJo software (Treestar). 
In vitro binding of PfTyrRS to various immune cells was performed by FACS using 
standard protocols. Dendritic cells and macrophage ThP1 cells were cultured on 
coverslips in 24-well plates (Gibson) and maintained in DMEM medium  
containing 20% (v/v) FBS and 1% antibiotics (Gibco). PfTyrRS and other control 
proteins were incubated with cells at several concentrations for 5 min to 2 h at 4 °C. 
Cells were washed twice in PBS and incubated with 2% formaldehyde (Sigma) for 
15 min and followed by incubation for 10 min with 0.1% saponin (Sigma).  
Primary and secondary antibodies were added as per manufacturer’s instructions 
(Molecular Probes). Fluorescence microscopy was performed on Nikon A1R 
confocal laser scanning microscope.
Western blots. P. falciparum (schizont stage) -infected human erythrocytes 
(1.5×107 parasites per ml) were enriched and parasites were cultured for 6–10 h  
to allow the maturation of schizonts, release of merozoites and their material54. 
Culture supernatant was collected in the presence of protease inhibitor cocktail 
after two rounds of centrifugation of 1,000 g for 15 min followed by 10,000 g  
for 20 min before freezing at  − 70 °C. Culture supernatant was subsequently used 
for western blotting using different antibodies against PfDTD (dilution, 1:500),  
Pf falcipain 2 (dilution, (1:1,000), PfMSP-1 (dilution, 1:1,000) and PfTyrRS  
(dilution, 1:500).
Cytokine secretion assays. Raw-264.7. cells, J774 murine cells, Dendritic cells 
(isolated from femur bone marrow of the mice C57BL/6) and human THP1 
macrophage cells (3×104) were cultured in RPMI medium with 10% FBS and 
1% antibiotics in 24-well format plates. Proteins were passed through polymyxin 
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beads (Sigma) before assays. LPS, PfTyrRS and control proteins were added to the 
medium at different concentrations. 100 µl of culture medium was collected and 
centrifuged after every 4, 24 and 48 h. Cytokines in the culture supernatant were 
detected by a Luminex microbead-based multiplexed assay (Bio-Plex manager 5.0) 
using commercially available kits according to the manufacturer’s protocol  
(Bio-Plex, Bio-Rad). All proteins were tested for endotoxin contaminations and 
passed through polymyxin beads (Sigma). LAL (Limulus Amebocyte Lysate) assay 
was performed to confirm that the proteins were endotoxin-free before each assay.
PfTyrRS interaction with human macrophages. Cultured human macrophages 
cells were mixed with PfTyrRS in absence or presence of different antibodies, 
namely anti-PfTyrRS, anti-CXCR1 and anti-CXCR2. Binding of PfTyrRS was tested 
using standard FACS protocols. In related experiments, cytokine profiling of these 
human macrophages was also done, either in absence or presence of antibodies 
used above. Cytokines released in culture supernatants were detected by a Luminex 
microbead-based multiplexed assay (Bio-Plex manager 5.0) using commercially 
available kits and according to the manufacturer’s protocol (Bio-Plex, Bio-Rad). 
Similar experiments were performed using various wild-type and mutant ELR-
based peptides. Human macrophages (ThP1 cells) were incubated with 100 nM of 
these peptides before addition of PfTyrRS. FACS and cytokine profiling were again 
done on all these samples as for the antibody treatment experiments.
Upregulation of endothelial cell receptors. Monocytes were obtained from buffy 
coat by Lymphoprep (Axis-Shield) gradient centrifugation, followed by adhesion-
mediated purification on tissue culture plastic. The cells were cultured for 3 days in 
RPMI-164 medium (Sigma) supplemented with 2 mM l-glutamine and 10%  
FBS to differentiate into macrophage. The recombinant PfTyrRS or control pro-
teins were added at a concentration of 1 µl ml − 1 on day 3, and cells were cultured 
continuously for 3 days. The culture supernatant was collected and centrifuged at 
13,000 g for 10 min to remove any debris; the supernatant was used for co-culture 
with endothelium. Primary pooled human umbilical vein endothelial cells  
(HUVEC) were obtained from Promocell). Cells were maintained in complete 
growth medium supplied by Promocell, according to the company’s instructions. 
To reduce variation, only cells at passage five to six were used. HUVEC were grown 
on 1% gelatin (Sigma) coated on 24-well plates with appropriate growth medium, 
until confluent. Then, the culture medium was replaced with either fresh medium 
alone, medium containing recombinant PfTyrRS or control protein (added at 
concentration 100 nM) or macrophage culture supernatants. These were incubated 
at 37 °C in 5% CO2 for 16 h. Endothelial cell markers were measured by fluores-
cence-activated cell sorting (FACScan; Becton Dickinson). Specific fluorescence-
conjugated antibodies, including APC Mouse anti-human CD54 (ICAM-1) and 
PE Mouse anti-human CD106 (VCAM-1) (Becton Dickinson), were used in this 
study. Nonspecific fluorescence was assessed using corresponding isotype control 
antibodies. The expression of endothelial surface proteins ICAM-1 and VCAM-1 
was indicated by geometric mean of the fluorescence intensity. PfTyrRS was  
subsequently used in a dose-dependent experiment for testing increased expression 
of ICAM-1, using the protocols described above.
PfTyrRS-GFP microscopy. The gene was amplified with genomic DNA of  
P. falciparum using following primers: forward-5′-CTCGAGATGATAATAT 
TAAAGGTTTTATTTA-3′ reverse-5′-GGTACCTTTTATTATTATAGAATAAC 
TTGTTC-3′ and cloned into pGEM-T vector (Promega). The insert was released 
from pGEMT and cloned between XhoI and KpnI in pGlux vector (Amersham). 
Transformations and clone propagation was done in Dh5α cells. Transfection of 
vectors into the parasite was done, as described earlier55. GFP-expressing infected 
erythrocytes were studied live or fixed at ambient temperature. Cells were viewed 
with a UPlanSApo ×100 1.4 oil objective on a Olympus IX81 Live Cell Imaging 
Inverted Microscope equipped with an Olympus F-View camera and primarily 
processed with analySIS LS Research software package. Captured images were then 
further processed using Photoshop and ImageJ. Pictures were adjusted to gain 
optimal contrast to visualize features of interest.
MTT assays. HUVEC cells at passage 5 were seeded at a concentration of 2×104 
cells per well (in 100 µl) and allowed to attach for 24 h on 1% gelatine (Sigma) 
coated on 96-well plates in complete growth medium under standard conditions 
(5% CO2, 95% humidity, 37 °C). Then, the cells were exposed to PfTyrRS at the  
concentrations indicated along with mutant PfTyrRS or HUVEC alone.  
The exposure time was 24 hours. Afterwards, the cell culture medium was  
withdrawn and in each well 10 µl MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide, Sigma] stock solution (5 mg ml − 1) was added, followed by 
an incubation period of 4 h. Afterwards, 100 µl per well stop solution (40 g SDS 
per 200 ml 50% DMF (NN-Dimethyformide, Sigma)) was added, followed by an 
incubation step overnight (37 °C). MTT metabolization as parameter for metabolic 
activity was recorded spectrophotometrically by Varioskan at 570 nm.
Statistical analyses. Data are derived from multiple independent experiments 
done in triplicates. Statistical analyses were conducted using SPSS software and  
values are presented as mean ± s.d. Significant differences between groups were 
determined by ANOVA followed by Tukey’s multiple comparison test (SPSS  
software). A value of P < 0.05 was accepted as an indication of statistical significance. 
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